Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-20

Clinical Trial Update: Improving Lung Cancer Screening Adherence by Overcoming Barriers for Vulnerable Populations

View source ↗

Summary

A completed trial from Thomas Jefferson University tested strategies to overcome barriers and improve lung cancer screening adherence in vulnerable populations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Thomas Jefferson University | Conditions: Lung Carcinoma | Status: COMPLETED